September, 2021

article thumbnail

What is Biogen and can they repair their reputation?

World of DTC Marketing

SUMMARY: If I were to ask you, “what type of company is Biogen?” what would be your response? I tried asking that of several colleagues in the industry, and they couldn’t come up with an answer. Biogen has lost its way and is in desperate need of a corporate rebranding. This week two colleagues, who worked at Biogen, left the company because they knew that the ax was coming after the failure of Aduhelm.

Insurance 222
article thumbnail

Podcast Feature: Marcus Cauchi on TheInquisitor Podcast

Authentic Influence Group

It was so much fun to join Marcus Cauchi on TheInquisitor Podcast! We covered several topics in our conversation. Here's a quick recap: We discuss why clear communication, that is easily digestible by your audience is essential if you're to have the impact you want in influencing people. The conversation evolves to cover body language, social engineering, authentic communication, persuasion vs influence vs manipulation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Episode 61 – A BrandRx For MedTech with Matthew Ray Scott, FEED. The Agency.

Medical Device Success

Reading time: 3 – 5 minutes. In other words, a brand prescription for MedTech. Matthew has walked the walk. Or, maybe I should say conquered the mountain of marketing and sales challenges. He says, “It’s the only thing busy docs care about. They care about you and I aligning with their perspective; relieving them of internal, external, philosophical and practical pains; and solving their problems.

Medical 130
article thumbnail

Prof Nigel Osborne: Science is catching up with historically pervasive ideas of ‘medical music’

Dominic Tyer

Internationally recognised composer, peace worker and musical therapy pioneer Professor Nigel Osborne talks about how his emerging field stands at an important threshold.

Medical 130
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

5 Order Management Trends Here To Stay

Salesforce

Porches and warehouses are dotted with parcels as more consumers and business buyers use ecommerce and portals instead of brick-and-mortar stores and sales reps. From flowers to medication to replacement parts for wind turbines, order management trends have changed. Nearly everything can be delivered — and customers like it that way. But a delayed package or inaccurate delivery data could drive a loyal customer to abandon your brand.

article thumbnail

A Roadmap For Value Based Selling

Integrity Solutions

A value based selling approach is intended to help salespeople focus their client conversations around creating product value versus price. This helps to better differentiate themselves in a highly competitive market. Yet, for all the buzz surrounding solution or value selling, many organizations still struggle to execute on it. What’s holding them back?

More Trending

article thumbnail

Podcast: Simple ways you can become a better persuasive communicator

Authentic Influence Group

I’m excited to share a podcast I recently had the opportunity to be part of. I sat down with Patrick Kothe of Mastering Medical Device to discuss simple ways you can become a better persuasive communicator. Here’s a snippet: So there are a number of factors that are involved in persuasive communication. First, you have to start with a foundation of really building trust with someone, because if I'm trying to communicate to you and persuade you to take on my project, or to give me more budget, if

Medical 130
article thumbnail

Episode 63 – In the C-Suite with Daniel Cloutier, CEO, LOK Corporation

Medical Device Success

Reading time: 2 – 2 minutes. Understanding how the worldwide distribution ecosystem works is a must for any MedTech professional. This conversation with Daniel Cloutier provides a window into this world and how LOK brings value to the manufacturers it represents with turnkey distribution. Daniel jokes that they are “Global minus One”. Take a guess at what country that is.

article thumbnail

John Lineen

Pharma Marketing Network

John Lineen is a senior executive with strong marketing, digital, analytics, and CX experience in the pharmaceutical industry. John’s specialty is managing, launching, measuring, and optimizing large-scale digital and omnichannel programs. He uses his global corporate (9+ years at Bristol Myers Squibb, GlaxoSmithKline), digital agency (12+ years @ Digitas Health), consulting (McKinsey & Company), start-up, and engineering background to deliver engaging content and services that help HCPs and

article thumbnail

How to boost your next Cycle Meeting?

Atrivity

For the pharmaceutical industry, cycle meetings are an indispensable element to reinforce key strategies, provide a market update and educate the sales force. Today, the way to reach healthcare professionals and train sales representatives has changed due to the COVID-19 pandemic. Adaptation to the new environment starts first within companies and especially in sales teams and other people who are in some way in contact with health professionals.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

The Latest on Return to Business Travel

Zymewire

We had all hoped for far more certainty around travel this coming fall – but as the delta variant continues to wreak havoc around the world, it may feel like the only thing you can plan for is…more uncertainty.

Sales 52
article thumbnail

Of course, ageism exists in pharma

World of DTC Marketing

SUMMARY: Those working in pharma know that ageism exists, especially in the sales force. Pharma has been purging older employees for some time, and when you reach the magic age of 50+, you’re going to be pushed to take “early retirement.” My workstation while at Lilly was right next to the sales training center. Some of the trainees looked like they were right out of school, but they all had one thing in common; they were young and great-looking.

Pharma 219
article thumbnail

Episode 003: The Role of Mentorship with Nick Spadea-Anello, Global President, Structural Heart at Boston Scientific

Med Device Careers

In today’s episode, we speak with Nick Spadea-Anello, Global President of Structural Heart at Boston Scientific. In our conversation, Nick shares his leadership and mentorship philosophy, what he describes as the three phases of a career, goal vs. growth orientation, and how he benchmarks success. Nick has a 28-year track record of building winning teams, pioneering new therapies, and growing new businesses, starting with Johnson and Johnson, followed by Guidant corporation and subsequently Bost

Medical 52
article thumbnail

Episode 62 – Digital Caffeine for Zoom Fatigue in MedTech with VidiPlus

Medical Device Success

Reading time: 2 – 2 minutes. Want your virtual prospecting to stand out? Bring your virtual presentations and messaging to life. This digital technology from VidiPlus will help. Dror Benjamin, CEO and his team have created a wonderful virtual tool. The way it brings your presentation items into the virtual window right next to you is very sophisticated.

article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

PMN Innovation Summit 2021

Pharma Marketing Network

Name *. First. Last. Title * Company * Email *. Name This field is for validation purposes and should be left unchanged. The post PMN Innovation Summit 2021 appeared first on Pharma Marketing Network.

article thumbnail

Agile launch execution requires the right digital tools

Tribeca Knowledge

T he pharmaceutical industry is embracing agile ways of thinking and working in its efforts to boost productivity, creativity, speed and efficiency, all the way from laboratory to patient. That includes ensuring agile launch execution. For pharmaceutical launch activities, agility is a function not just of organisational structures or attitudinal change but of the technologies used to make those activities more visible, accessible and manageable.

article thumbnail

Equitable Evaluations for a Hybrid Workforce: An Intro for Leaders

ALULA

Through all the changes that the pandemic has imposed on the corporate world, critical aspects of the business can fall by the wayside. Performance evaluations are one such aspect, and in these uncertain times, keeping those evaluations fair and equitable is of utmost importance.

52
article thumbnail

The hypocrisy of big pharma

World of DTC Marketing

SUMMARY: Pfizer will earn over 26 billion dollars from their COVID vaccine, while Moderna and J&J also look to their vaccines for more profit dollars. The suggestion by Pfizer’s CEO that drug pricing negotiations with the government would slow innovation is PR doubletalk. Recently Pfizer’s CEO sent a video message to company employees urging them to fight proposed government drug price negotiations and expressing frustration with Congress, considering using the projected savings

Pharma 214
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

5 Keys in the Multichannel relationship with the HCP

Atrivity

The way in which the pharmaceutical industry engages with healthcare professionals (HCPs) has changed dramatically in the last year. Restrictions on face-to-face interactions have given way to greater use of remote and digital channels. Have they worked? Laboratories have had to adapt in record time to the new needs, hitting and missing in those attempts due to the speed of change, but now, with the new normal, we can stop and think about what can be improved.

article thumbnail

On the Virtual Road: Sales Tales with Scott Ballenger - One egg or two?

Zymewire

The pandemic has cost us many things, including, for too many of us, the ability to connect with our colleagues in person. At Zymewire, we recognized that risk early on and have made a concerted effort to preserve our culture and community despite the lack of in-person collaboration.

Sales 52
article thumbnail

PMN Innovation Summit 2021

Pharma Marketing Network

Telehealth: Past. Present. Future. Once considered a novelty, over the past 18 months, Telehealth has risen to a prominent position in the continuum of care. Listen to how pharmaceutical brands and clinicians are adapting to this new modality and are pivoting their promotional efforts to ensure that they can leverage the Telehealth channel effectively.

article thumbnail

Clarify’s CEO talks with PM360 about how pharma’s addressing health inequities with SDoH insights

Clarify Health

There is overwhelming evidence to suggest that social determinants of health (SDoH) impact the onset and progression of health conditions, the care that patients receive, their access to testing and treatment, and health outcomes. The pharmaceutical industry has a critical role to play in ensuring underserved communities and vulnerable patients receive equal access to care and treatment through better disease education, greater clinical trial diversity, innovative assistance programs, and new po

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Return to Office: Questions Employees Should Answer to Successfully Prepare

ALULA

In our series on preparing for return to office (RTO) and hybrid work arrangements, we have focused primarily on what organizations and leaders need to consider in making these arrangements successful. However, at the end of the day, the success of these transitions ultimately depends on how all employees—regardless of title or position—are able to be engaged, safe, productive, and successful.

52
article thumbnail

The drug industry can’t fight change

World of DTC Marketing

SUMMARY: John F. Kennedy said, “Change is the law of life, and those who look only to the past and present are certain to miss the future”. Change is coming for one simple reason; our country can’t sustain the current costs of healthcare. Today’s pharma CEOs should prepare their organizations for the future, not wasting money with lobbying costs.

article thumbnail

Comparing Clinical Specialist Roles

Med Device Careers

How is the Cardiac Clinical Specialist role different from other medical specialities? The medical device industry is one of the most stable and fast-growing industries in the world. In 2019, the global medical device market reached a value of nearly $457B. COVID-19 reinforced to everyone the importance of medical devices and technological solutions in healthcare.

Medical 52
article thumbnail

Digital Strategy Principles for Healthcare Manufacturers

KBK Communications

As a healthcare manufacturer you are responsible for making sure the products you sell are of high quality and that the people who buy them know what to do with them. It is also important to understand how digital strategies can help your company grow, improve your customer service, and maintain a competitive edge in today's market. This blog will discuss some common principles that all healthcare manufacturers should have in place when it comes to a digital strategy.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

EU Medical Device Safety Monitoring & Reporting Conference | October 26-28, 2021 | Berlin, Germany and Virtual

Pharma Marketing Network

Maximizing Patient Safety and Sustaining Long Term Quality Through Enhanced Device Surveillance while navigating the EU Regulatory Landscape. In recent years the European Union has updated their requirements for Medical Device reporting following the FDA in the United States mainly with the EU Medical Device Regulation. Medical device companies continue to look at new strategies, tools, and technologies to achieve a more comprehensive medical device monitoring and reporting framework to ensure t

Safety 52
article thumbnail

Modernizing provider growth strategies with next-gen referral analytics

Clarify Health

Health systems and provider groups need robust growth strategies to thrive in uncertain times. Improving referral patterns and identifying areas of opportunity to align physicians can maximize volume growth. However, to achieve growth goals and understand what is driving referral volume in- and out-of-network, providers need actionable insights. With the right insights, providers can evaluate and prioritize physicians for alignment, identify opportunities to redirect out-of-network referrals bac

article thumbnail

4 Metrics Critical to Measuring Success of a Hybrid Work Environment

ALULA

As we start thinking about a sustainable hybrid workforce model, it’s important to also consider how we’ll know that hybrid models get the benefits we need in terms of employee engagement and business results. That means leaders can’t forget to measure progress and impact.

52
article thumbnail

DTC messages need to evolve

World of DTC Marketing

SUMMARY: With patients staying away from their doctors because of COVID, DTC messages need to add incentives and better messaging to get people to take action rather than wait. No one message will do this, however. Messages need to evolve in these special times. My doctor’s office recently sent me an email that they had plenty of telehealth appointments available for patients who didn’t want to come to the office.

Doctors 199
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.